CytoDyn Market Cap

CytoDyn has a market cap or net worth of $322.20 million as of June 30, 2025. Its market cap has increased by 117.08% in one year.

Market Cap

322.20M

Enterprise Value

333.11M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.26

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 322.20M, an increase of 5,718.39%. That is a compound annual growth rate of 23.01%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	322.20M	139.31%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	779.84M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Glass House Brands	459.12M
American Oncology Network	414.48M
Northwest Biotherapeutics	349.23M

Market Cap Rankings